Table 2 Node-splitting analysis for PONV and urine retention
Name | Direct Effect | Indirect Effect | Overall | P-Value |
|---|---|---|---|---|
A: PONV | ||||
 EA, GA | 1.02 (−0.47, 2.42) | 0.88 (−0.31, 2.09) | 0.91 (0.02, 1.88) | 0.89 |
 EA, SA | 0.25 (−1.15, 1.85) | −1.24 (−2.46, −0.20) | −0.68 (−1.58, 0.25) | 0.10 |
 EA, LIA | −2.46 (−4.33, − 0.74) | −1.38 (−2.44, − 0.38) | −1.74 (−2.67, − 0.89) | 0.29 |
 EA, NBA | −2.03 (−4.03, − 0.76) | −1.46 (− 2.79, − 0.21) | −1.80 (− 2.82, − 0.93) | 0.47 |
 GA, LIA | − 2.43 (− 4.62, − 0.74) | −2.77 (−3.90, − 1.76) | −2.64 (−3.70, − 1.75) | 0.78 |
 GA, NBA | −1.80 (− 4.09, − 0.11) | − 2.95 (− 4.22, − 1.99) | − 2.71 (−3.88, − 1.74) | 0.41 |
 GA, SA | −1.78 (− 2.62, − 0.96) | −0.91 (− 2.41, 0.54) | −1.57 (− 2.27, − 0.88) | 0.30 |
 GA + ISB, ISB | − 1.03 (− 3.23, 0.72) | −1.62 (− 3.68, 0.32) | −1.23 (− 2.76, 0.23) | 0.65 |
 LIA, SA | 0.83 (− 0.50, 2.13) | 1.29 (0.13, 2.66) | 1.08 (0.20, 2.04) | 0.62 |
 LIA, NBA | − 0.08 (− 0.90, 0.65) | 0.04 (−1.68, 1.49) | −0.07 (− 0.81, 0.63) | 0.89 |
B: Urine retention | ||||
 EA, GA | −0.47 (− 2.91, 1.86) | −1.37 (− 4.68, 1.53) | −0.68 (− 2.52, 0.87) | 0.60 |
 EA, NBA | −2.93 (−5.49, − 0.99) | − 1.35 (−5.92, 2.38) | −2.59 (− 4.56, − 1.00) | 0.45 |
 EA, SA | −0.66 (− 4.75, 2.23) | −0.67 (− 3.34, 1.44) | −0.76 (− 2.71, 0.86) | 0.96 |
 GA, SA | 0.20 (− 1.68, 2.06) | − 0.94 (− 4.47, 2.55) | −0.08 (− 1.60, 1.43) | 0.55 |
 NBA, SA | 0.81 (− 2.34, 4.35) | 2.50 (− 0.56, 5.47) | 1.84 (− 0.26, 3.93) | 0.48 |